Production (Stage)
PMV Pharmaceuticals, Inc.
PMVP
$0.97
$0.022.11%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -18.97% | -16.55% | -9.45% | 13.81% | -13.73% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -15.90% | 75.75% | 133.06% | 101.60% | 22.40% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 0.00% | 0.00% | 0.00% |
Total Current Assets | -19.24% | -15.31% | -7.64% | 14.90% | -13.21% |
|
|||||
Total Current Assets | -19.24% | -15.31% | -7.64% | 14.90% | -13.21% |
Net Property, Plant & Equipment | -92.48% | -91.85% | -4.29% | -6.53% | -6.16% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 30.22% | 23.68% | 34.44% | 0.55% | -42.04% |
Total Assets | -27.98% | -24.14% | -14.38% | -1.93% | -6.73% |
|
|||||
Total Accounts Payable | 318.28% | 103.24% | 22.94% | 29.92% | -51.58% |
Total Accrued Expenses | -43.77% | -25.16% | 13.49% | -28.20% | 20.90% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -58.64% | -58.69% | -- | 6,294.44% | 213.17% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -19.07% | 2.43% | 26.57% | -0.54% | 13.86% |
|
|||||
Total Current Liabilities | -19.07% | 2.43% | 26.57% | -0.54% | 13.86% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -93.89% | -93.26% | -5.32% | -8.65% | -7.99% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -56.61% | -42.53% | 9.28% | -4.85% | 1.74% |
|
|||||
Common Stock & APIC | 1.50% | 1.72% | 2.07% | 9.13% | 9.71% |
Retained Earnings | -18.72% | -18.94% | -17.49% | -17.61% | -25.02% |
Treasury Stock & Other | 165.12% | -37.95% | 215.49% | 43.60% | -11.21% |
Total Common Equity | -24.72% | -21.98% | -16.71% | -1.60% | -7.60% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -24.72% | -21.98% | -16.71% | -1.60% | -7.60% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -24.72% | -21.98% | -16.71% | -1.60% | -7.60% |
|